Patent · US Active

Neublastin variants

US8263553B2 · kind B2 · utility

2Cited by

52References

219Claims

0Family size

Assignee

BIOGEN IDEC MA INC. · US

Inventors

Anthony Rossomando · Grafton, US
Laura Silvian · Newton, US
R. Blake Pepinsky · Arlington, US

Key dates

Filing date	Aug 18, 2005
Grant date	Sep 11, 2012
Priority date	—
Expiry date	Apr 3, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods for folding proteins belonging to the transforming growth factor beta superfamily are disclosed. The compositions and methods allow for the folding of such proteins when produced in an expression system that does not yield a properly folded, biologically active product.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.